When: Confirmed close below $174.37 on volume >2.5M for two consecutive sessions

Then: Reassess toward Underweight with hard stop execution

HOLD - do not add, do not trim; wait for September FOMC resolution and Q2 earnings to clarify EPS revision trajectory before reassessing

• 3.6% forward EPS decline is a leading indicator concern, not noise - every bear market was preceded by estimates walking down while the tape held up
• 31.2% EBITDA expansion is misleading due to easy comp from Q2 2025's $484M impairment charge
• Lease escalators protect revenue but not interest expense on $45B debt stack; refinancing rate increase from 4.2% to 4.8% adds ~$270M annual interest expense
• Dividend coverage ratio of 1.18x leaves minimal cushion; $176M buyback resumption is token optics (0.2% of market cap), not real capital allocation confidence
• Technical analysis shows ATR compression has no directional bias; MACD histogram collapsed from +0.76 to +0.01; 50 SMA at $170.97 below 200 SMA at $175.35 (death cross)
• Polymarket 72% hike probability is high-conviction signal, not tail risk; August jobs report blowout + inflation odds near 100% indicate regime change
• Valuation gap thesis (39% below fair value) requires multiple unconfirmed positive catalysts simultaneously: Fed dovish pivot, FFO estimate revisions, satellite fears fading, and multiple expansion
• Downside risk of $13-15 with 50% probability of hawkish catalyst within weeks versus upside requiring four aligned positive surprises

→ vs aggressive: Forward EPS decline of 3.6% is not 'rounding error' - it's the leading indicator that historically precedes bear markets; EBITDA expansion is distorted by easy comp from $484M impairment

→ vs aggressive: Polymarket 72% hike probability is not 'Monday morning quarterbacking' - it's been accurate over 18 months; labor market reversal means Fed setup is opposite of late 2024

→ vs aggressive: Lease escalators do not protect interest expense line; $270M incremental annual interest expense on $45B debt stack from 50bps rate increase is math, not narrative

→ vs aggressive: ATR compression has no directional bias; MACD histogram going from +0.76 to +0.01 is momentum exhaustion, not 'coiled spring'; death cross ($170.97 vs $175.35) hasn't been repaired

→ vs aggressive: Simply Wall St. 39% undervaluation is one model's output, not a tradable signal; consensus bullishness at turning points is consistently wrong

→ vs aggressive: 1.18x FCF coverage is 'okay' not 'robust'; $176M buyback resumption is 0.2% of market cap - token signal, not capital allocation shift; real confidence is $500M+ buybacks or debt paydown

→ vs aggressive: September FOMC 25bps hike at 50% odds is base case, not tail risk - in that scenario AMT breaks below $174.37 and rate-sensitive sector drops 8-15%

Maintain HOLD; widen stop from $174.37 to $172 or use discretionary mental stop requiring confirmed close below $172 on volume; add signal for confirmed close above $179.82 on volume above 2.5M to reconsider adding on pullback.

• Forward EPS revision ($7.27 to $7.01) is a yellow flag requiring monitoring for continuation, not a rounding error or definitive thesis.
• Q1 2026 EBITDA expansion ($1,435M to $1,884M) is genuine operating leverage—impairment was in Q2 2025, not Q1 2025.
• AMT is not 'duration-protected'; this is a leveraged real asset whose value is determined by cap rates.
• Revenue escalators protect top line but not income statement from refinancing pain; $270M incremental interest estimate is directionally correct.
• Polymarket 72% hike probability has shifted macro tape hawkish; 50% probability hike is a coin flip, not a base case.
• Technicals: neutral-to-slightly-bullish near-term momentum against bearish intermediate trend; ATR compression has no directional bias.
• 39% valuation gap contingent on DCF assumptions; 50 bps WACC change can flip case from 39% upside to 10% upside.
• AMT trades at 22x book and 24x earnings—fairly valued to modestly undervalued on fundamentals.
• Dividend coverage is adequate to strong: 1.18x FCF coverage, 1.74x operating cash flow coverage; dividend growth is more vulnerable than the dividend itself.
• Probability-weighted expected value: 40% hawkish September FOMC ($162-168), 35% hold ($170-180), 25% dovish breakout ($190+); EV is roughly flat.
• Stop-loss at $174.37 sits on 50 SMA—a level every technician is watching; hawkish FOMC could gap through and execute stop at worse price.
• Reassessment triggers: September FOMC, Q2 earnings, forward EPS revision trajectory, confirmed close above $179.82 on volume above 2.5M.

→ vs aggressive: Forward EPS revision should not be dismissed as 'rounding error dressed up as a thesis'—trajectory of revisions matters, not just one revision.

→ vs aggressive: AMT is not 'duration-protected'—this is a category error; it's a leveraged real asset, not a duration-protected cash flow stream.

→ vs aggressive: Sell-side not catching up could mean the market sees something analysts are missing, not that the market is wrong.

→ vs aggressive: ATR compression has no directional bias and should not be read as a coiled spring; aggressive analyst is reading the chart backward to fit his thesis.

→ vs aggressive: Asymmetric risk-reward claim ($50-60 upside vs $13-15 downside) does not exist on a probability-weighted basis; expected value is roughly flat.

→ vs conservative: Q1 2026 EBITDA expansion is not lapping an impaired quarter—the $484M impairment was in Q2 2025, not Q1 2025; Q1 2025 EBITDA was $1,435M.

→ vs conservative: MACD flattening (histogram +0.76 to +0.01) is consolidation before continuation as often as before reversals; 'momentum exhausting' is a selective read.

→ vs conservative: Valuation gap is contingent on DCF assumptions; AMT at 22x book and 24x earnings is not a bubble or distressed multiple; fairly valued to modestly undervalued.

→ vs conservative: 1.74x operating cash flow coverage makes dividend structurally safe through realistic 12-month stress; 'something gives eventually' implies imminent stress when data does not support that.